Caixin
Caixin Global – Latest China News & Headlines

Home >

ABOUT US

CX Tech is Caixin Global's real-time tech news portal, featuring 24-hour news, short-form analysis, and roundups from business and tech media in China.

LATEST
Chinese Social Media Platform Weibo Punished for Spreading Pornographic Content
Trending in China: Could “76 Days”, a Doc About Covid-19 in Wuhan, Win an Oscar?
Huawei to Establish Biggest-Ever Overseas Flagship Store in Riyadh
China’s First High-School Education Group Files for $100m US IPO
Danish Pension PBU Backs First Close of New SE Asia-Focused Women’s Fund
Tencent Music to Buy Audiobook Platform Lazy Audio for $416 million
Shanghai-Based Robot Developer Closes $46 Million Funding Round
Trending in China: Top Broadcast Exec Questions if Esports Are Really a Sport – Cue Heated Debate
Chinese Video Streamer iQiyi Targets U.S. Market With Animation on Nickelodeon
Chinese Majority Owned Lotus Announce EV Sports Car Venture With Renault’s Alpine
Chinese New Film Materials Maker HIUV on Track to Raise $227m in STAR Market IPO
Jordan Slam Dunks on Copycat Chinese Sportswear Brand Forcing Them to Change Their Name
Trending in China: Will ‘Chinese Baijiu’ Name Change Propel It To Global Dominance?
EHang Pioneers Self-Flying Drones for Tourists in Greater Bay Area City
TCL Squashes Rumours it is Withdrawing From North America Amid Empty Shelves
Chinese PE Fund Manager CICC Capital Secures $649m Second Close of Biomedicine Fund
WeRide Receives $310 Million as Beijing Opens Highways to Autonomous Car Tests
China’s Orchid Asia Leads Funding in Delivery Platform Fantuan, Edtech Startup Ivydad
U.S.-Listed Video Streamer Bilibili Files for Secondary Listing in Hong Kong, CNBC Reports
Dining Delivery Pay Dispute Leads Man to Set Himself on Fire
Global First as Potential Nasal Spray Covid-19 Vaccine Proceeds to Clinical Trial Phase

By Wen Simin and Ingrid Luan / Sep 16, 2020 12:38 PM / World

China has begun human trials of a nasal spray Covid-19 candidate vaccine that could serve as an alternative to injections.

The vaccine has become the first of its kind in the world to proceed to the clinical trial phase, according to the WHO’s list of candidate vaccines released last Wednesday.

Scientists hope that the vaccine puffed into the nose could be effective in preventing the coronavirus, which spreads through the respiratory tract.

It could be delivered along with an injected vaccine as part of to mount a multipronged approach.

Another advantage of the nasal spray vaccine is that it can be easily self-administered.

The vaccine has been co-developed by HKU, Fujian province’s Xiamen University as well as vaccine-maker Beijing Wantai Biological Pharmacy Enterprise Co. Ltd.

Contact editor Joshua Dummer (joshuadummer@caixin.com)

Read full story: Chinese Covid-19 Vaccine Candidate Becomes First Nasal Spray to Start Clinical Trial


Share this article
Open WeChat and scan the QR code